GDNF/NT-3 |
EVA NGC |
luminal release |
rat facial |
5 mm |
six weeks |
NGC + GDNF showed highest nerve regeneration level. |
Barras et al. [78] |
VEGF |
silicone NGC |
suspension (matrigel) |
rat sciatic |
10 mm |
one, two, four and 26 weeks |
VEGF increased angiogenesis, SC migration and nerve regeneration. |
Hobson [79] |
NGF |
poly(phenylene ethynylene) (PPE) |
PPE microsphere release |
rat sciatic |
10 mm |
12 weeks |
NGF increased nerve regeneration versus control conduits. |
Xu et al. [80] |
GDNF |
collagen + PLGA NGC |
luminal release (various rates) |
rat peroneal |
3 mm |
12 weeks |
number of myelinated fibres tripled for all rates versus no GDNF group. |
Piquilloud et al. [81] |
NGF |
porous PCL conduit |
suspension/luminal release |
rat sciatic |
12 mm |
four, eight weeks |
NGF luminal release showed superior regeneration to suspension. |
Chang [82] |
GDNF + NGF |
collagen + PLGA NGC |
luminal release |
rat sciatic |
10 mm |
two weeks |
significant increase in early peripheral nerve regeneration. |
Madduri et al. [9] |
GDNF/NGF |
silicone NGC |
affinity-based fibrin matrix |
rat sciatic |
13 mm |
four, eight, 12 weeks |
12 weeks motor recovery of GDNF greater than isograft. |
Wood et al. [83] |
CNTF |
chitosan/PLGA NGC |
luminal release |
dog tibial |
25 mm |
12 weeks |
functional recovery comparable to that of autograft. |
Shen et al. [84] |
NGF |
PLLA-CL fibrous NGC |
core shell nanofibrous release |
rat sciatic |
10 mm |
12 weeks |
NGC showed similar functional recovery regeneration to autograft. |
Liu et al. [85] |